BANK VONTOBEL/PUT/MERCK & CO./120/0.1/20.12.24 Stock

Warrant

DE000VD3SDA9

Real-time Boerse Frankfurt Warrants 04:12:43 2024-05-20 am EDT
0.3 EUR -3.23% Intraday chart for BANK VONTOBEL/PUT/MERCK & CO./120/0.1/20.12.24
Current month-16.22%
1 month-43.64%
Date Price Change
24-05-20 0.3 -3.23%
24-05-17 0.31 0.00%
24-05-16 0.31 +3.33%
24-05-15 0.3 -18.92%
24-05-14 0.37 0.00%

Real-time Boerse Frankfurt Warrants

Last update May 20, 2024 at 04:12 am EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying MERCK & CO., INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VD3SDA
ISINDE000VD3SDA9
Date issued 2024-04-09
Strike 120 $
Maturity 2024-12-20 (215 Days)
Parity 10 : 1
Emission price 0.47
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.56
Lowest since issue 0.29
Spread 0.02
Spread %6.25%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
131.2 USD
Average target price
141.6 USD
Spread / Average Target
+7.96%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW